Numinus Wellness Inc. Reports Q1 2022 Results
Ended the quarter with a strong cash position of $53.9 million Revenues grew 245% year-over-year to $0.8 million for the quarter Generated gross profit of $50,965 during the quarter, representing a 6.5% gross margin Well-positioned to offer psychedelic-assisted psychotherapy ... [Read]
Summa Silver Samples Multiple Undrilled High-Grade Veins Above 1,000 g/t Silver Equiv. at Mogollon, New Mexico
Large Drill Programs Planned for 2022 as the Company Drives Towards Mineral Resource Estimates Vancouver, British Columbia – January 20, 2022 – Summa Silver Corp. (TSXV:SSVR)(OTCQB:SSVRF) (“Summa” or the “Company”) is pleased to provide an update ... [Read]
Numinus Announces Key Milestones in MAPS-Sponsored MDMA-Assisted Therapy for PTSD Clinical Trial
Numinus has received approvals from Health Canada and the Institutional Ethics Review Board VANCOUVER, BC, Jan. 19, 2022 – Numinus Wellness Inc. (TSXV:NUMI) (“Numinus” or the “Company”), a leader in psychedelics-focused mental healthcare, is pleased ... [Read]
Numinus Submits Clinical Trial Application for Phase 1 Trial on Proprietary Psilocybin Product
The trial evaluates Numinus’ first trademarked product and patent-pending production process VANCOUVER, BC, Jan. 14, 2022 – Numinus Wellness Inc. (TSXV:NUMI)(“Numinus“), a leader in psychedelics-focused mental healthcare, is pleased to announce that it has formally ... [Read]
Logiq Restructures Management Team
With 2020-2021 Strategic Initiatives Successfully Achieved, Company Pivoting to Customer Acquisition and M&A NEW YORK, Jan. 13, 2022 – Logiq Inc. (NEO:LGIQ)(OTCQX:LGIQ), a global provider of award-winning consumer acquisition solutions, today announced a restructuring of the ... [Read]
Summa Silver Announces the Grant of Stock Options to Officers, Directors and Consultants
Vancouver, British Columbia – January 7, 2022 – Summa Silver Corp. (TSXV:SSVR)(OTCQB:SSVRF) (“Summa” or the “Company“) has approved the grant of 1,435,000 incentive stock options to officers, directors, and consultants of the Company. The options vest quarterly ... [Read]
Numinus to Host Q1 2022 Results Conference Call on January 13, 2022
VANCOUVER, BC, Jan. 5, 2022 – Numinus Wellness Inc. (TSXV:NUMI)(OTCPK:LKYSF) (“Numinus” or the “Company”) (TSX: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, will release its financial results for ... [Read]
Numinus Wellness Commends Health Canada on Special Access Programme Amendments to Restore Potential Access to Psychedelic Medicines
Policy amendment allows practitioners to request access to psychedelic drugs for patients with serious or life-threatening conditions on a case-by-case basis VANCOUVER, BC, Dec. 22, 2021 – Numinus Wellness Inc. (TSXV:NUMI)(OTCPK:LKYSF) (“Numinus” or the “Company”), a ... [Read]
Numinus Wellness Inc. to Commence Trading on the TSX on December 16, 2021
Numinus will ring the TSX opening bell to celebrate this milestone VANCOUVER, BC, Dec. 14, 2021 – Numinus Wellness Inc. (TSXV:NUMI)(OTCPK:LKYSF) (“Numinus” or the “Company”), a mental health care company advancing innovative treatments and safe, ... [Read]
Summa Silver Intersects 50 Meter Vein Zone with Visible Mineralization in First Hole at Mogollon, New Mexico
Core Photos Reveal Extensive Vein Zone Vancouver, British Columbia–Summa Silver Corp. (TSXV:SSVR)(OTCQB:SSVRF)(FSE: 48X) (“Summa” or the “Company“) is pleased to provide an update from on-going drilling at the high-grade silver-gold Mogollon Property, near Silver City, ... [Read]